Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
By: Jan Juřica, Roman Goněc, Adela Bártová and Jana Gregorová
Authors
Jan Juřica
Faculty of Medicine, Department of Pharmacology, Masaryk University, Brno, Czech Republic
Masaryk Memorial Cancer Institute, Brno, Czech Republic
Faculty of Pharmacy, Department of Pharmacology and Toxicology, Masaryk University, Brno, Czech Republic
Roman Goněc
Masaryk Memorial Cancer Institute, Brno, Czech Republic
Adela Bártová
Faculty of Medicine, Department of Pharmacology, Masaryk University, Brno, Czech Republic
Jana Gregorová
Faculty of Medicine, Department of Biochemistry, Masaryk University, Brno, Czech Republic
DOI: https://doi.org/10.2478/afpuc-2022-0006 | Journal eISSN: 2453-6725
Language: English
Page range: 84 - 86
Submitted on: Apr 25, 2022
Accepted on: May 10, 2022
Published on: Jun 18, 2022
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
© 2022 Jan Juřica, Roman Goněc, Adela Bártová, Jana Gregorová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.